In the News | Charles River

   
 
 
   
   

Guarding the Heart
The best time to discover that a drug has cardiovascular liabilities is early in the drug research process. Assays that identify toxicities in preclinical phases can help.
Drug Discovery & Development – June 1, 2009

The cardiovascular system is a vital part of the human body. It is responsible for important tasks such as supplying nutrients, removing waste, distributing hormones and regulatory substances, maintaining osmotic balance and homeostasis. It is also one of the more delicate systems in the human body and can be impacted by both cardiovascular and non-cardiovascular drugs. As a result, drug development programs are complex and often require multidisciplinary research when assessing potential cardiovascular toxicity...Read the full article.

   
Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Mar 09 - New Endotoxin Data Management Soft...
Mar 08 - Rodent Intravenous Infusion Capabi...
Apr 07-Apr 10 - La Grande Motte, France - Perspectives in Percutaneous Penetration: 12t...
Mar 22-Mar 23 - San Francisco, CA - 2010 PMF Bacterial Endotoxin Summit
May 05-May 05 - Tempe, AZ - Rodent Colony and Disease Management Considerations – A Sem...
view all
Veterinary Pathologist II Reno, NV
Corporate Sr. VP, Corporate Development 

Charles River Laboratories, Inc.